NCT00511810View on ClinicalTrials.gov

Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Major Depressive Disorder
Interventions
DRUG

Low Dose Fish Oil

Omega-3 Fatty Acids 2.4g/day in capsule form (4 capsules per day)

DRUG

High Dose Fish Oil

Liquid omega-3 fatty acid 15 g/day (2 tablespoons/day)

Trial Locations (1)

45219

University of Cincinnati, Cincinnati

All Listed Sponsors
collaborator

The Inflammation Research Foundation

OTHER

lead

University of Cincinnati

OTHER

NCT00511810 - Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder | Biotech Hunter | Biotech Hunter